Djamila Ouaret
Oxford, ENG OX39DS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Critical roles for EGFR and EGFR-HER2 clusters in EGF binding of SW620 human carcinoma cells.
Journal: Journal of the Royal Society, Interface
Published: May 25, 2022
In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
Journal: Anticancer research
Published: September 06, 2020
PLAP -CAR T cells mediate high specific cytotoxicity against colon cancer cells.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 31, 2020
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.
Journal: Cancer biology & medicine
Published: September 14, 2019
Cellular polarity modulates drug resistance in primary colorectal cancers via orientation of the multidrug resistance protein ABCB1.
Journal: The Journal of pathology
Published: March 29, 2018
ICG-001 affects DRP1 activity and ER stress correlative with its anti-proliferative effect.
Journal: Oncotarget
Published: February 08, 2017
Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 02, 2016
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2015
Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Journal: Oncotarget
Published: January 05, 2015
Protein kinase C β inhibition by enzastaurin leads to mitotic missegregation and preferential cytotoxicity toward colorectal cancer cells with chromosomal instability (CIN).
Journal: Cell cycle (Georgetown, Tex.)
Published: December 09, 2014
Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling.
Journal: Cancer research
Published: August 30, 2014
Last Updated: 09/26/2026